ELANElanco Animal Health Inc

NYSE elanco.com


$ 14.80 $ 0.31 (2.14 %)    

Monday, 19-Aug-2024 15:59:58 EDT
QQQ $ 481.15 $ 6.24 (1.31 %)
DIA $ 409.09 $ 2.37 (0.58 %)
SPY $ 559.11 $ 5.30 (0.96 %)
TLT $ 97.90 $ 0.45 (0.46 %)
GLD $ 231.62 $ -0.38 (-0.16 %)
$ 14.82
$ 14.59
$ 14.81 x 200
-- x --
$ 14.44 - $ 14.83
$ 8.52 - $ 18.80
3,008,225
na
7.16B
$ 1.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-26-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-07-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-28-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 05-14-2019 03-31-2019 10-Q
23 02-20-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 parasites--vectors-publishes-study-showing-elancos-credelio-flea-and-tick-protection-product-achieves-fastest-tick-kill-in-12-hours-and-maintains-effectiveness-throughout-dosing-interval

Study Highlights Importance Of Tick Protection As CDC Reports Over 45,000 Human Tickborne Disease Cases Between 2019-2022

 correction-elanco-animal-health-q2-2024-adj-eps-030-beats-024-estimate-sales-1184b-beat-1156b-estimate

Elanco Animal Health (NYSE:ELAN) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0...

 elanco-forecasts-q3-revenue-of-102b-105b-with-adjusted-eps-of-009-014-compared-to-consensus-of-1079b-and-018-respectively

2024 Third Quarter(dollars in millions, except per share amounts) Guidance     Revenue $1,020to$1,050Reported Net Income $368to...

 merck-animal-health-completes-acquisition-of-elanco-animal-health-assets

Merck Animal Health announced the purchase of Elanco Animal Health's aquaculture business.Merck & Company (NYSE:MRK) co...

 citigroup-elanco-animal-health-and-a-tech-stock-cnbcs-final-trades

Analysts expect Citigroup to report good earnings on Friday. Stephanie Link chose Elanco for its new products. Corning increase...

 piper-sandler-maintains-neutral-on-elanco-animal-health-lowers-price-target-to-16

Piper Sandler analyst David Westenberg maintains Elanco Animal Health (NYSE:ELAN) with a Neutral and lowers the price target...

 barclays-maintains-overweight-on-elanco-animal-health-lowers-price-target-to-21

Barclays analyst Balaji Prasad maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and lowers the price target from...

 elanco-animal-health-shares-sink-on-unexpected-label-update-for-canine-dermatology-drug

Elanco Animal Health shares drop after updates on FDA approval timelines for Zenrelia and Credelio Quattro. Zenrelia's U.S....

 piper-sandler-reiterates-neutral-on-elanco-animal-health-raises-price-target-to-19

Piper Sandler analyst David Westenberg reiterates Elanco Animal Health (NYSE:ELAN) with a Neutral and raises the price targe...

 barclays-maintains-overweight-on-elanco-animal-health-raises-price-target-to-23

Barclays analyst Balaji Prasad maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION